IN DEPTH: The NCI Subscription Deal with Celera | GenomeWeb

NEW YORK, July 11 – In the often-contentious world of private versus public genomic initiatives, everybody appears to be happy about the National Cancer Institute’s subscription agreement with Celera Genomics.

The deal, which allows individual NCI principal investigators to use lab budgets to access the data and tools in the Celera Discovery System and mouse and SNP datasets, was six months in the making, according to sources at NCI and Celera. The agreement was announced on Monday. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.